HRTX Operating Cash Flow (Statement)

Heron Therapeutics Inc · Operating Cash Flow (Statement)

HRTX logo

HRTX Operating Cash Flow (Statement)

Latest reported-$11.61M
HRTX TTM Cash from Operations (-$3.40M → -$11.61M)
High-resolution chart · PNG

HRTX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-4,830,321
-4,518,745
-3,116,002
-688,649
5,842
-759,234
-800,000
-100,000
-600,000
600,000
-1,500,000
-2,200,000
-1,400,000
-2,500,000
0
-1,300,000
-2,200,000
-2,100,000
-6,100,000
-8,300,000
-10,200,000
-11,800,000
-8,500,000
-8,900,000
-8,700,000
-8,500,000
-8,600,000
-8,100,000
-8,100,000
-9,800,000
-11,700,000
-11,600,000
-7,900,000
-4,100,000
-3,900,000
-3,000,000
-5,500,000
-5,200,000
-3,800,000
-2,900,000
-2,600,000
-3,700,000
-3,400,000
-3,900,000
-3,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.